Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,880
Closed -$201K 123
2017
Q3
$201K Sell
3,880
-1,147
-23% -$55.9K 0.04% 123
2017
Q2
$246K Sell
5,027
-230
-4% -$10.7K 0.05% 119
2017
Q1
$247K Hold
5,257
0.05% 117
2016
Q4
$252K Sell
5,257
-482
-8% -$22.1K 0.05% 117
2016
Q3
$227K Hold
5,739
0.05% 117
2016
Q2
$203K Sell
5,739
-17
-0.3% -$663 0.05% 121
2016
Q1
$225K Hold
5,756
0.05% 122
2015
Q4
$215K Hold
5,756
0.06% 122
2015
Q3
$241K Sell
5,756
-280
-5% -$13.1K 0.06% 118
2015
Q2
$301K Hold
6,036
0.08% 112
2015
Q1
$271K Buy
+6,036
New +$271K 0.07% 114

Other funds holding MET

Jacobs & Co's MET Position: Q4 2017 in Review

Jacobs & Co sold out of MetLife (MET) in Q4 2017, closing a stake of 3,880 shares — an estimated $201K sold.

Jacobs & Co first reported a position in MET in Q1 2015 and held it in 11 quarters. The position peaked at $301K in Q2 2015. 1,085 funds tracked by Wall St. Rank hold MET as of Q4 2017.

  • Jacobs & Co reported no remaining MetLife position as of Q4 2017 after selling out during the quarter.
  • Jacobs & Co sold 3,880 MetLife shares in Q4 2017, an estimated $201K.
  • Jacobs & Co first reported a position in MetLife in Q1 2015 and held it in 11 quarters.
  • Jacobs & Co's MetLife position peaked at $301K in Q2 2015.
  • 1,085 funds tracked by Wall St. Rank held MetLife as of Q4 2017.

Based on Jacobs & Co's 13F filing for Q4 2017, filed 9 Feb 2018.